We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×
News

CBD Can Kill Antibiotic-Resistant Gonorrhea Bacteria, Study Finds

Based on these promising results, the study’s authors say that CBD could form the basis of a new class of antibiotics, the first for resistant bacteria in 60 years.

Read More

NIST’s Cannabis Testing Program Enters Second Phase, Seeks New Labs

The federal study aims to improve the testing standards used throughout the cannabis lab sector. Any lab interested in participating in the next phase of the project has until February 5 to enroll.

Read More

USDA Releases Final Rules on Hemp, Effective From March 22

In a win for hemp farmers, the final rule widens the margin of error for THC levels in hemp plants before a cultivator is declared criminally negligent. However, several high-profile sticking points remain, including some guidelines on sampling.

Read More

ProVerde’s Maine Cannbis Lab Shut Down For Unlicensed Testing

Responding to Analytical Cannabis, ProVerde president Chris Hudalla explained that the Maine lab was “in operation before there were any requirements or mechanisms for licensing of marijuana testing laboratories in Maine.”

Read More

Cannabis Smoke Raises Blood Toxin Levels, But Not as Much as Tobacco Smoke, Study Finds

The researchers also found that tobacco smokers, and those who smoke a mixture of cannabis and tobacco, had elevated blood levels of acrolein, which is linked to an increased risk of developing heart disease.

Read More

Colorado Regulators Recall Cannabis Products Due to Mold Contamination

Any consumer in possession of such a product has been advised by the Colorado Department of Revenue to return it to the initial retailer.

Read More

UK Regulator Grants Second Commercial License to Grow Medical Cannabis

The Jersey-based company has become the second cultivator in the British Isles to be licensed by the UK Home Office to grow pharmaceutical-grade cannabis for profit.

Read More

FDA Outlines Plan to Improve CBD Research Data

The administration said it intends to use poison control records and other databases to better identify CBD products associated with adverse events. A new opt-in registry for CBD consumers is also in the works.

Read More

Young Medical Cannabis Patients More Likely to Experience Withdrawal Symptoms, Finds Study

Following a two-year longitudinal study, the researchers concluded that cannabis withdrawal should be considered on a scale of severity, rather than as distinct subtypes of withdrawal syndromes.

Read More

 
Advertisement